516 related articles for article (PubMed ID: 35684353)
1. A Review of Twenty Years of Research on the Regulation of Signaling Pathways by Natural Products in Breast Cancer.
Naeem M; Iqbal MO; Khan H; Ahmed MM; Farooq M; Aadil MM; Jamaludin MI; Hazafa A; Tsai WC
Molecules; 2022 May; 27(11):. PubMed ID: 35684353
[TBL] [Abstract][Full Text] [Related]
2. Recent Development in Indole Derivatives as Anticancer Agents for Breast Cancer.
Kaur K; Jaitak V
Anticancer Agents Med Chem; 2019; 19(8):962-983. PubMed ID: 30864529
[TBL] [Abstract][Full Text] [Related]
3. Exploring the anti-cancer potential of dietary phytochemicals for the patients with breast cancer: A comprehensive review.
Sohel M; Aktar S; Biswas P; Amin MA; Hossain MA; Ahmed N; Mim MIH; Islam F; Mamun AA
Cancer Med; 2023 Jul; 12(13):14556-14583. PubMed ID: 37132286
[TBL] [Abstract][Full Text] [Related]
4. Anticancer properties of medicinal plants and their bioactive compounds against breast cancer: a review on recent investigations.
Khan MI; Bouyahya A; Hachlafi NEL; Menyiy NE; Akram M; Sultana S; Zengin G; Ponomareva L; Shariati MA; Ojo OA; Dall'Acqua S; Elebiyo TC
Environ Sci Pollut Res Int; 2022 Apr; 29(17):24411-24444. PubMed ID: 35064485
[TBL] [Abstract][Full Text] [Related]
5. Exploration of therapeutic applicability and different signaling mechanism of various phytopharmacological agents for treatment of breast cancer.
Singh V; Kumar K; Purohit D; Verma R; Pandey P; Bhatia S; Malik V; Mittal V; Rahman MH; Albadrani GM; Arafah MW; El-Demerdash FM; Akhtar MF; Saleem A; Kamel M; Najda A; Abdel-Daim MM; Kaushik D
Biomed Pharmacother; 2021 Jul; 139():111584. PubMed ID: 34243623
[TBL] [Abstract][Full Text] [Related]
6. Effects and mechanisms of dietary bioactive compounds on breast cancer prevention.
Ganesan K; Du B; Chen J
Pharmacol Res; 2022 Apr; 178():105974. PubMed ID: 34818569
[TBL] [Abstract][Full Text] [Related]
7. Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy.
Tewari D; Patni P; Bishayee A; Sah AN; Bishayee A
Semin Cancer Biol; 2022 May; 80():1-17. PubMed ID: 31866476
[TBL] [Abstract][Full Text] [Related]
8. Drug Delivery of Natural Products Through Nanocarriers for Effective Breast Cancer Therapy: A Comprehensive Review of Literature.
Yap KM; Sekar M; Fuloria S; Wu YS; Gan SH; Mat Rani NNI; Subramaniyan V; Kokare C; Lum PT; Begum MY; Mani S; Meenakshi DU; Sathasivam KV; Fuloria NK
Int J Nanomedicine; 2021; 16():7891-7941. PubMed ID: 34880614
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory Potential of Dietary Nutraceuticals on Cellular PI3K/Akt Signaling: Implications in Cancer Prevention and Therapy.
Narayanankutty A
Curr Top Med Chem; 2021; 21(20):1816-1831. PubMed ID: 34279200
[TBL] [Abstract][Full Text] [Related]
10. Natural products derived from medicinal plants and microbes might act as a game-changer in breast cancer: a comprehensive review of preclinical and clinical studies.
Singla RK; Wang X; Gundamaraju R; Joon S; Tsagkaris C; Behzad S; Khan J; Gautam R; Goyal R; Rakmai J; Dubey AK; Simal-Gandara J; Shen B
Crit Rev Food Sci Nutr; 2023 Nov; 63(33):11880-11924. PubMed ID: 35838143
[TBL] [Abstract][Full Text] [Related]
11. Brain metastasis in breast cancer: focus on genes and signaling pathways involved, blood-brain barrier and treatment strategies.
Chhichholiya Y; Ruthuparna M; Velagaleti H; Munshi A
Clin Transl Oncol; 2023 May; 25(5):1218-1241. PubMed ID: 36897508
[TBL] [Abstract][Full Text] [Related]
12. PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials.
Dey N; De P; Leyland-Jones B
Pharmacol Ther; 2017 Jul; 175():91-106. PubMed ID: 28216025
[TBL] [Abstract][Full Text] [Related]
13. Modulation of oncogenic transcription factors by bioactive natural products in breast cancer.
Hasanpourghadi M; Pandurangan AK; Mustafa MR
Pharmacol Res; 2018 Feb; 128():376-388. PubMed ID: 28923544
[TBL] [Abstract][Full Text] [Related]
14. Research Progress of Plant-Derived Natural Products against Drug-Resistant Cancer.
Liu W; Wang Y; Xia L; Li J
Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542707
[TBL] [Abstract][Full Text] [Related]
15. Targeting lactate metabolism and glycolytic pathways in the tumor microenvironment by natural products: A promising strategy in combating cancer.
Kooshki L; Mahdavi P; Fakhri S; Akkol EK; Khan H
Biofactors; 2022 Mar; 48(2):359-383. PubMed ID: 34724274
[TBL] [Abstract][Full Text] [Related]
16. Gigantol inhibits proliferation and enhances DDP-induced apoptosis in breast-cancer cells by downregulating the PI3K/Akt/mTOR signaling pathway.
Huang J; Liu C; Duan S; Lin J; Luo Y; Tao S; Xing S; Zhang X; Du H; Wang H; Huang C; Wei G
Life Sci; 2021 Jun; 274():119354. PubMed ID: 33737087
[TBL] [Abstract][Full Text] [Related]
17. Review deciphering potent therapeutic approaches targeting Notch signaling pathway in breast cancer.
Pandey P; Khan F; Choi M; Singh SK; Kang HN; Park MN; Ko SG; Sahu SK; Mazumder R; Kim B
Biomed Pharmacother; 2023 Aug; 164():114938. PubMed ID: 37267635
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor signaling as a target for novel breast cancer therapeutics.
Renoir JM; Marsaud V; Lazennec G
Biochem Pharmacol; 2013 Feb; 85(4):449-65. PubMed ID: 23103568
[TBL] [Abstract][Full Text] [Related]
19. Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents.
Hashem S; Ali TA; Akhtar S; Nisar S; Sageena G; Ali S; Al-Mannai S; Therachiyil L; Mir R; Elfaki I; Mir MM; Jamal F; Masoodi T; Uddin S; Singh M; Haris M; Macha M; Bhat AA
Biomed Pharmacother; 2022 Jun; 150():113054. PubMed ID: 35658225
[TBL] [Abstract][Full Text] [Related]
20. Natural products: An upcoming therapeutic approach to cancer.
Dutta S; Mahalanobish S; Saha S; Ghosh S; Sil PC
Food Chem Toxicol; 2019 Jun; 128():240-255. PubMed ID: 30991130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
